Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia

This study has been completed.
Sponsor:
Collaborator:
Bristol-Myers Squibb
Information provided by:
Stanford University
ClinicalTrials.gov Identifier:
NCT00160329
First received: September 8, 2005
Last updated: July 19, 2011
Last verified: July 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2009
  Primary Completion Date: April 2007 (Final data collection date for primary outcome measure)